
CAS 301326-22-7
:Formule :C19H19N5O
InChI :InChI=1S/C19H19N5O/c1-13-6-4-5-7-17(13)23-22-15-8-9-16(14(2)12-15)21-19(25)18-10-11-20-24(18)3/h4-12H,1-3H3,(H,21,25)
Code InChI :LKTNEXPODAWWFM-UHFFFAOYSA-N
SMILES :CC1=CC=CC=C1N=NC2=CC(=C(C=C2)NC(=O)C3=CC=NN3C)C
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
9 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
CH-223191
CAS :Formule :C19H19N5ODegré de pureté :>97.0%(HPLC)(qNMR)Couleur et forme :White to Light yellow to Light orange powder to crystalMasse moléculaire :333.401-Methyl-N-(2-methyl-4-(o-tolyldiazenyl)phenyl)-1H-pyrazole-5-carboxamide
CAS :Formule :C19H19N5ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :333.3871CH-223191
CAS :Formule :C19H19N5ODegré de pureté :≥ 98.0%Couleur et forme :White to yellow or orange powder to crystalsMasse moléculaire :333.391-Methyl-N-(2-Methyl-4-(o-Tolyldiazenyl)Phenyl)-1H-Pyrazole-5-Carboxamide
CAS :1-Methyl-N-(2-Methyl-4-(o-Tolyldiazenyl)Phenyl)-1H-Pyrazole-5-CarboxamideFormule :C19H19N5ODegré de pureté :≥98%Masse moléculaire :333.39CH 223191
CAS :Produit contrôléApplications CH 223191 is a novel antagonist of the aryl hydrocarbon receptor.
References Choi, E., et. al.: Mol. Pharmacol., 81, 3 (2012)Formule :C19H19N5OCouleur et forme :NeatMasse moléculaire :333.39CH-223191
CAS :1-Methyl-N-(2-methyl-4-(o-tolyldiazenyl)phenyl)-1H-pyrazole-5-carboxamideFormule :C19H19N5ODegré de pureté :98%Masse moléculaire :333.39CH-223191
CAS :CH-223191, a specific aryl hydrocarbon receptor (AhR) antagonist, inhibited TCDD-induced luciferase activity with an IC50 of 0.03 μM. High-Quality, Low-Cost!Formule :C19H19N5ODegré de pureté :99.01% - 99.87%Couleur et forme :Orange SolidMasse moléculaire :333.3871CH-223191
CAS :CH-223191 is a potent and selective DNA polymerase chain reaction (PCR) antagonist that prevents the synthesis of double-stranded DNA. It binds to the aryl hydrocarbon receptor (AHR), which is involved in mediating toxic effects of certain environmental pollutants. CH-223191 has been shown to be an AHR antagonist, preventing activation of proinflammatory cytokines such as IL-6 and IL-8 in human hepg2 cells. This agent also inhibits the expression of proinflammatory genes, including MMP-9, COX-2, and TNF-α. Additional studies have shown that CH-223191 has lead optimization potential for anticancer drugs due to its ability to inhibit proliferation and induce apoptosis in cancer cells at low levels.Formule :C19H19N5ODegré de pureté :Min. 95%Couleur et forme :PowderMasse moléculaire :333.40 g/mol







